Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Research Fellowship: Awardees & Reports

The ESMO Research Fellowship was first introduced in 1989 and is awarded as a one-year project with the option of a second-year prolongation upon request and subsequent approval by the Fellowship Committee. 

Depending on the focus of the submitted fellowship project young oncologists are offered the following research experience:

  • Focus Translational - Comprehensive bench-to-bedside training providing the opportunity to learn about the latest developments in translational cancer research.
  • Focus Clinical - Training in clinical research in renowned European cancer centres and supports efforts to expand professional networks through collaboration with institutions of excellence


Pasquale Lombardi

Project: A machine-learning algorithm on digital pathology as an immunologic predictor of outcome to immunotherapy in hepatocellular carcinoma
Home institute: Fondazione Policlinico Universitario Agostino Gemelli (IRCCS), Rome, Italy
Host institute: Imperial College London, United Kingdom
Sponsor: BMS
Start date: TBC

Maximilian Mair

Project: Harnessing theranostics to address brain tumour heterogeneity in time and space
Home institute: Medical University of Vienna, Austria
Host institute: LMU Munich, Germany
Sponsor: ESMO
Start date: April 2024

Natalie Ngoi 

Project: Multi-omic characterization of the mechanisms of resistance to nectin-4-directed protein-drug-conjugates in advanced solid tumours
Home institute: National University Cancer Institute, Singapore
Host institute: Institute Gustave Roussy, Paris, France
Sponsor: ESMO
Start date: April, 2024

Nadia Saoudi Gonzalez

Project: Multi-omics profiling of colorectal cancer patients response outliers to first line chemotherapy
Home institute: Vall d'Hebron University Hospital- Vall d'Hebron Institute of Oncology, Barcelona, Spain
Host institute: IFOM ETS - the AIRC Institute of Molecular Oncology, Milan, Italy
Sponsor: ESMO
Expected start date: April 2024

Gil Awada

Project: Imaging-guided de-escalation strategies in the neoadjuvant management of early-stage triple-negative and HER2-positive breast cancer
Home institute: UZ Brussel - Universitair Ziekenhuis Brussel, Belgium
Host institute: Netherlands Cancer Institute (NKI), Amsterdam, Netherlands
Sponsor: ESMO
Start date: September, 2023


Nicole Brighi

Project: High sensitivity bespoke liquid biopsy analysis to characterize and track cabazitaxel-resistant clones in metastatic castration-resistant prostate cancer.
Home institute: IRST - Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRCCS S.r.l., Meldola, Italy
Host institute: University College of London Cancer Institute, London, United Kingdom
Sponsor: ESMO
Start date: October 2022

Laetitia Collet

Project: Molecular characterization of intratumor heterogeneity and tumor microenvironment in high grade serous ovarian cancer and BRCA1/2 mutant breast cancers using spatial transcriptomics
Home institute: Université Claude Bernard Lyon 1, Lyon, France
Host institute: Breast Cancer Translational research Laboratory (BCTL), Jules Bordet Institut, Brussels, Belgium
Sponsor: ESMO
Start date: November 2022

Santiago Moragon Terencio

Project: Genomic landscape of early-stage luminal breast cancer by single-cell analysis (Tapestri project)
Home institute: Hospital Clinico Universitario de Valencia, Valencia, Spain
Host institute: Gustave Roussy, Villejuif, France
Sponsor: ESMO
Start date: October 2023

Anthony Turpin

Project: PARP inhibitors associated tumour immune microenvironment changes in pancreatic ductal adenocarcinoma
Home institute: CHU Lille - Hopital Claude Huriez, Lille, France
Host institute: Vall d'Hebron Institute of Oncology, Barcelona, Spain
Sponsor: BMS
Expected start date: May 2023

Andreas Koulouris

Project: Evaluation of clinical and molecular variables and the development of prognostic tools in patients with advanced non small cell lung cancer (NSCLC) with brain metastases
Home institute: University General Hospital of Heraklion, Heraklion, Greece
Host institute: Karolinska Institutet, Stockholm, Sweden
Sponsor: ESMO
Start date: June 2022


Jose Carlos Benitez

Project: EMT and immune suppression cancer activation pathways of Non-Small cell Lung Cancer (NSCLC) by Single Cell targeted gene expression analysis to assess resistance to immunotherapy and early relapse 
Home institute: Mutua Terrassa University Hospital, Barcelona, Spain
Host institute: Gustave Roussy Cancer Center, Villejuif, France 
Sponsor: ESMO
Start date: September 2021

Marcela Carausu 

Project: Interrogating triple-negative breast cancer heterogeneity and its microenvironment at the single-cell level
Home institute: Institute of Oncology "Prof. Dr. Alexandru Trestioreanu", Bucharest, Romania
Host institute: Institut Jules Bordet, Brussels, Belgium
Sponsor: ESMO
Start date: March 2022

Gaia Giannone

Project: Predictive biomarkers for response to nintedanib in ovarian clear cell carcinoma 
Home institute: Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
Host institute: Imperial College London (Hammersmith Hospital Campus), London, United Kingdom
Sponsor: ESMO
Fellowship period: November 2021 – November 2022

Download the report

Pernelle Lavaud

Project: Analysis of samples from the SCLC REACTION trial: Discovery of biomarkers to optimize treatment  
Home institute: Institut Gustave Roussy, Villejuif, France
Host institute: Cancer Research UK (CRUK) Manchester Institute, Alderley Edge, United Kingdom 
Sponsor: ESMO
Start date: November 2021

Giulia Mazzaschi

Project: A micro-CT based radiomic approach to identify radio-immune signatures in preclinical models of head and neck and lung cancers   
Home institute: University Hospital of Parma, Parma, Italy
Host institute: Institut Gustave Roussy, Cedex, France
Sponsor: ESMO
Fellowship period: November 2021 – November 2022

Download the report

Pablo Cresta Morgado

Project: Integration of genomic testing and patient expectations into prostate cancer treatment decision-making  
Home institute: Angel H. Roffo Oncology Institute, Buenos Aires, Argentina
Host institute: Vall d’Hebron Institute of Oncology, Barcelona, Spain
Sponsor: BMS
Fellowship period: October 2021– October 2022

Download the report

Pedro Rocha

Project: Met inhibition in combination with anti-PD-1/PD-L1 as a new therapeutic approach in Small Cell Lung Cancer  
Home institute: The University of Texas MD Anderson Cancer Center - Main BuildingHouston, United States
Host institute: Instituto Hospital del Mar de Investigaciones Médicas, Barcelona, Spain
Sponsor: ESMO
Start date: October 2021

John Greene

Project: The impact of obesity on survival outcomes following drug treatment for advanced malignancy recorded within the Systemic Anti-Cancer Therapy (SACT) database
Home institute: St James's Hospital, Dublin, Ireland
Host institute: University of Oxford, Oxford, United Kingdom
Sponsor: ESMO
Fellowship period: October 2021 – October 2022 

Download the report

Tiago Padua

Project: A personalized approach of neoadjuvant therapy, including immunotherapy and bladder preservation, for muscle-invasive urothelial bladder carcinoma (MIBC) 
Home institute: : Universidade Federal de Sao Paulo (UNIFESP), Sao Paulo, Brazil
Host institute: San Raffaele Hospital and Scientific Institute, Milan, Italy
Sponsor: ESMO
Start date: September 2021


Elisabeth Bergen

Project: Molecular classification of pancreatic cancer by gene expression analysis of circulating tumor DNA
Home institute: Vienna General Hospital (AKH) - Medizinische Universität Wien, Vienna, Austria
Host institute: Department of Gastroenterology and Gastrointestinal Oncology Department Georges Pompidou European Hospital,  Sorbonne Paris-Cité,  Université Paris-Descartes, Paris, France
Sponsor: ESMO
Fellowship period: October 2020 – October 2021

Download the report

Luca Cantini

ProjectENSURE study - Dendritic cell therapy combined with surgery in mesothelioma
Home institute: Università Politecnica delle Marche - AOU Ospedali Riuniti Ancona, Ancona, Italy
Host institute: Erasmus MC Cancer Centre, Rotterdam, Netherlands
Sponsor: ESMO
Fellowship period: January 2021 – December 2022

Read the publication

Giulia Costanza Leonardi

ProjectThe role of tumor-specific CD8+ T cells in tumor evolution and response to immune checkpoint inhibitors in cervical cancer patients
Home institute: Università degli Studi di Catania, Catania, Italy
Host institute: Cancer Research Center of Toulouse (CRCT, Inserm UMR 1037) and Institut Universitaire du Cancer de Toulouse – Oncopole (IUCT-O), Toulouse, France 
Sponsor: ESMO
Fellowship period: January 2021 – January 2023

Long Nguyen

ProjectInvestigating the molecular mechanisms that regulate human breast cancer stem cell function in response to systemic therapy
Home institute: Princess Margaret Cancer Centre, Toronto, Canada
Host institute: Cancer Research UK Cambridge Institute, Cambridge, United Kingdom
Sponsor: ESMO
Fellowship period: April 2021– April 2023

Andri Papakonstantinou

Project: Impact of microbiota on breast cancer prognosis and treatment efficacy
Home institute: Karolinska Institutet, Solna, Sweden
Host institute: Vall d’Hebron Institute of Oncology, Barcelona, Spain
Sponsor: ESMO
Fellowship period: January 2021- December 2022

Francesco Schettini

Project: Prognostic and therapeutic significance of treatment-induced intrinsic subtypes and genomic changes in Luminal breast tumors
Home institute: Azienda Ospedaliera Universitaria Federico II, Naples, Italy
Host institute: August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
Sponsor: ESMO
Start date: January 2021 (prolonged for the 2nd year)

Madeleine Strach

ProjectCharacterisation of appendiceal adenocarcinoma by transcriptomic analysis and correlation with clinical outcomes: a step towards rational therapeutics
Home institute: Chris O'Brien Lifehouse, Lilyfield, Australia
Host institute: The Christie Colorectal and Peritoneal Oncology Research Group, Manchester Cancer Centre, Manchester, United Kingdom
Sponsor: ESMO
Start date: August 2021

Francesco Cortiula

Project: Concurrent chemotherapy and PROton therapy coMpared to photon therapy, followed by Durvalumab maintEnance in sTagE III NOn-Small Cell Lung Cancer (NSCLC) (PROMETEO study): immunological and hematological effects
Home institute: CRO Aviano National Cancer Institute, Udine, Italy
Host institute: Maastricht University Medical Center+, Maastricht, Netherlands
Sponsor: ESMO
Fellowship period: January 2021 – January 2022

Download the report

Aljosja Rogiers

Project: A prospective observational study to identify a composite biomarker for prediction and early detection of immunotherapy-related adverse events (irAEs)
Home institute: Melanoma Institute Australia, Sydney, Australia​
Host institute: The Royal Marsden NHS Foundation Trust, London, United Kingdom
Sponsor: ESMO
Fellowship period: May 2021 – May 2022

Download the report


Gabor Dobos

Project: Evaluation of a combination of biomarkers for an early diagnosis of mycosis fungoides
Home institute: Charité - Universitätsmedizin Berlin, Germany
Host institute: Hôpitaux Universitaires, Saint-Louis Lariboisière Fernand-Widal, France 
Sponsor: Roche
Fellowship period: January 2020 - June 2021

Download the report

Eleonora Ghisoni

Project: Characterisation of stromal TILs specificity and activity in immune excluded epithelial ovarian cancer
Home institute: Institute for Cancer Research and Treatment of Candiolo- FPO/IRCCS, Italy
Host institute: CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Sponsor: ESMO
Fellowship period: August 2019 - June 2021

Read the publication | Download the report

Asuka Kawachi-Kawai

Project: Identification of novel therapeutic targets in desmoplastic small round cell sarcoma (DSRCT)
Home institute: National Cancer Center Research Institute, Tokyo, Japan
Host institute: Institut Gustave Roussy, Villejuif, France
Sponsor: ESMO
Fellowship period: November 2019 - November 2022

Ignacio Matos Garcia

Project: Impact of human FCγR gene polymorphism on hyper-progression disease with anti-PD1 inhibitors based on Antibody mediated PD1+ T cell phagocytosis
Home institute: Vall d'Hebron Institute of Oncology, Barcelona, Spain
Host institute: UCL Cancer Institute, London, United Kingdom
Sponsor: Roche
Fellowship period: March 2020 - December 2022

Laura Mezquita Pérez

Project: RADAR study: Molecular signature of radioactivity-induced lung cancer based on radon-induced lung cancer in rats from the French Atomic Energy Commission cohort 
Home institute: Institut Gustave Roussy, Villejuif, France
Host institute: Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Sponsor: BMS
Fellowship period: February 2020 – January 2022

Mariela Vasileva-Slaveva

Project: Breast cancer metastasis and lipid metabolism implication
Home institute: Alexandrovska University Hospital, Sofia, Bulgaria
Host institute: Innsbruck Medical University, Austria
Sponsor: ESMO
Fellowship period: November 2019 – October 2020

Download the report

Giacomo Bregni

Project: A phase II trial of neoadjuvant regorafenib in combination with nivolumab and short-course radiotherapy in intermediate-risk, stage II-III rectal cancer (REGINA)
Home institute: Ospedale Policlinico S. Martino IRCCS, Genoa, Italy
Host institute: Institut Jules Bordet, Brussels, Belgium
Sponsor: ESMO
Fellowship period: January 2020 – September 2021

Download the report 

Carlo Cattrini

Project: BRCA2MEN: an international, multicentre, observational and ambispective study to validate the predictive value of germline BRCA2 mutations in selecting first-line metastatic castration-resistant prostate cancer (mCRPC) treatment
Home institute: San Martino Polyclinic Hospital, Italy
Host institute: National Cancer Research Center (CNIO), Madrid, Spain
Sponsor: ESMO
Fellowship period: January 2020 – January 2021

Download the report


Michael-John Devlin

Project: The Immune Microenvironment of a Murine Model of Clear Cell Ovarian Cancer
Home institute: University College Londo Hospital, London, United Kingdom
Host institute: Institute, Queen Mary University of London, London, United Kingdom
Sponsor: Roche
Fellowship period: September 2018 – August 2019

Download the report

Elisa Gobbini

Project: Role of BDCA3high dendritic cells and type III interferon in anti-tumor immune responses
Home institute: Azienda Ospedaliera Universitaria San Luigi Gonzaga, Orbassano, Italy
Host institute: Léon Bérard research center, Lyon, France
Sponsor: BMS
Fellowship period: September 2018 – September 2020

Download the report

Christoph Oing

Project: Illuminating the genomic landscape of hypoxia-driven early metastatic prostate cancer
Home institute: University Medical Center Hamburg-Eppendorf, Germany
Host institute: Manchester Cancer Research Centre, Manchester, United Kingdom
Sponsor: Roche
Fellowship period: September 2018 – September 2019

Download the report

Federica Papaccio

Project: Development of “living organoid biobank” derived from colorectal cancer patients. Towards a personalized medicine in cancer
Home institute: Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy
Host institute: INCLIVA Biomedical Research Institute, Department of Medical Oncology, Hospital Clinico Universitario de Valencia
Sponsor: Amgen
Fellowship period: September 2018 – September 2020

Download the report

Daniel Eiger

Project: Cardiotoxicity Related to Systemic Anti-HER2 Therapies: sub-analysis of ALTTO and APHINITY trials
Home institute: Centro Paulista de Oncologia, Sao Paolo, Brazil
Host institute: Institute Jules Bordet, Brussels, Belgium
Sponsor: Novartis
Fellowship period: September 2018 – September 2019

Download the report

Read the publication


Angelika Bezan

Project: Liquid biopsy by apheresis
Home institute: Medical University of Graz, Austria
Host institute: Institute of Cancer Research, The Royal Marsden, Sutton, United Kingdom
Sponsor: Roche
Fellowship period: October 2017 – October 2018

Giulia Martini

Project: An integrative bedside to bench approach for discovery and validation of new biomarkers of resistance in metastatic Colorectal Cancer (mCRC) by liquid biopsy and development of preclinical cancer models
Home institute: Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy
Host institute: Vall d'Hebron Institute of Oncology, Barcelona, Spain
Sponsor: Amgen
Fellowship period: October 2017 – October 2019

Bernadetta Pellegrino

Project: Exploiting the DNA-damage response upon PARP inhibition in homologous recombination deficient tumors to maximize the activity of anti-PD-L1 therapy
Home institute: Azienda Ospedaliera di Parma, Italy
Host institute: Vall d'Hebron Institute of Oncology, Barcelona, Spain
Sponsor: Roche
Fellowship period: July 2018 – July 2019

Download the report

Antonio Di Meglio

Project: Health Behaviors and Long-term Treatment Toxicity Among Breast Cancer Survivors: A Quantitative Analysis in the French Prospective CANTO Cohort
Home Institute: IRCCS AOU San Martino, Genoa, Italy
Host institute: Institut Gustave Roussy, Villejuif, France
Sponsor: ESMO
Fellowship period: September 2017 – September 2018

Bruno Duso

Project: A Phase I-II Investigation of Pembrolizumab in Combination with Oral Metronomic Cyclophosphamide in Patients with Locally Recurrent, Inoperable, and/or Metastatic Inflammatory Breast Cancer with Lymphangitic Spread to the Chest Wall
Home Institute: Hospital Moinhos de Vento, Porto Alegre, Brazil
Host institute: Istituto Europeo di Oncologia, Milan, Italy
Sponsor: ESMO
Fellowship period: August 2017 – August 2018

Download the report

Sheraz Markar

Project: Lasting Symptoms after Esophageal Resection (LASER) 
Home Institute: St. Mary's Hospital Imperial College, London, United Kingdom
Host institute: Karolinska Instituttet, Stockholm, Sweden
Sponsor: Novartis
Fellowship period: September 2017 – September 2018


Annalisa Milano

Project: Next-generation expression analysis (NanoString) to develop prognostic and predictive gene signatures for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
Home institute: St. Andrea Hospital, Medical and Surgical Sciences and Translational Medicine, Rome, Italy
Host institute: Agostino Gemelli Hospital, Rome, Italy
Sponsor: Roche
Fellowship period: October 2016 – November 2018

Francesca Maria Rizzo

Project: Different expression of CXCR4 on CTCs from NET patients with or without skeletal metastases
Home institute: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Department of Biomedical Sciences and Human Oncology, Bari, Italy
Host institute: UCL Cancer Institute – Department of Oncology, London, United Kingdom
Sponsor: Roche
Fellowship period: August 2016 – September 2018

Sarah Kammerer

Project: Clear Cell Renal Cell Carcinoma: development of novel treatment strategies targeting cancer stem cells and identification of new predictive biomarkers
Home institute: Medical University Graz, Institute of Biophysics, Graz, Austria
Host institute: Max Delbrück Centrum for Molecular Medicine (MDC), Berlin, Germany
Sponsor: Amgen
Fellowship period: September 2016 – September 2017

Download the report

Matteo Lambertini 

Project: Liquid Biomarkers during Fertility Preserving Procedures in BRCA Mutated Breast Cancer Patients
Home Institute: IRCCS AOU San Martino - IST, Genova, Italy
Host institute: Jules Bordet Institute, Breast Cancer Translational Research Laboratory, Brussels, Belgium
Sponsor: Amgen
Fellowship period: August 2016 – August 2018

Read the publication

Piera Gargiulo

Project: Inflammation markers and prognostic model of survival and toxicity in patients with advanced pancreatic cancer (APC) receiving palliative Gemcitabine-based chemotherapy: insights from the SAKK 44/00-CECOG/PAN.1.3.001
Home institute: Istituto Nazionale Tumori- I.R.C.C.S - Fondazione Pascale, Napoli, Italy
Host institute: Swiss Group for Clinical Cancer Research SAKK, Bern, Switzerland
Sponsor: Novartis
Fellowship period: July 2016 – October 2017

Download the report

Read the publication


Lisa Derosa 

Project: BRAVE - Brain metastases and pancReatic metastases: A clinicopathological comparison of Various facets of the tumour hEterogeneity in renal cell carcinoma
Home Institute: Azienda Ospedaliero, Universitaria S.Chiara, Pisa, Italy
Host Institute: Institut Gustave Roussy, Villejuif, France
Sponsor: Roche
Fellowship period: November 2015 – November 2017

Download the report

Zoltan Lohinai

Project: The role of blood and lymph vessels in malignant pleural mesothelioma: From biology to therapy
Home Institute: National Koranyi Institute of Pulmonology, Budapest, Hungary
Host Institute: Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Austria
Sponsor: Roche
Fellowship period: August 2015 – August 2017

Download the report

Blanca Navarro Rodrigo

Project: Targeting mutational signatures in colorectal cancer
Home Institute: INCLIVA - University of Valencia, Spain
Host Institute: University Hospital of Lausanne, Ludwig Cancer Research Center, Switzerland
Sponsor: Amgen
Fellowship period: October 2015 – October 2017

Petr Szturz

Project: Evaluation of MET expression and inhibition in squamous cell carcinomas of the head and neck
Home Institute: University Hospital Brno, Czech Republic
Host Institute: Hopital Bichat - Claude Bernand, Paris, France
Sponsor: Amgen
Fellowship period: November 2015 – November 2016

Download the report

Alberto Verlicchi

Project: Therapeutic opportunities for Squamous cell carcinoma of the lung: the Hedghog pathway and beyond
Home Institute: Ospedale Civile di Ravenna, Italy
Host Institute: Germans Trias i Pujol, Barcelona, Spain
Sponsor: Roche
Fellowship period: September 2015 – September 2016

Download the report

Sara Valpione

Project: Study of prognostic factors in patients with BRAF-mutant metastatic melanoma treated with targeted therapies
Home Institute: University of Padova, Italy
Host Institute: The Christie NHS Foundation Trust, University of Manchester, United Kingdom
Sponsor: Novartis
Fellowship period: October 2015 – October 2016



Vincenza Conteduca

Project: Novel biological profiles of sensitivity and/or resistance to Abiraterone and/or Enzalutamide in patients with castration-resistant prostate cancer
Home Institute: Istituto Tumori della Romagna I.R.S.T., Meldola, Italy
Host Institute: The Institute of Cancer Research, Sutton, United Kingdom
Sponsor: Roche
Fellowship period: October 2014 – October 2016

Download the report

Valentina Gambardella
Valentina Gambardella

Project: The Role of MET in Primary and Acquired Resistance in HER2 positive gastric cancer
Home Institute: AOU Seconda Università degli Studi di Napoli (AOU-SUN), Napoli, Italy
Host Institute: INCLIVA Biomedical Research Institute, Department of Hematology and Medical Oncology, Hospital Clinico de Valencia, University of Valencia, Spain
Sponsor: Amgen
Fellowship period: October 2014 – October 2016

Colin Lindsay
Colin Lindsey

Project: Assessing the clinical application of circulating tumour cells in non-small cell lung cancer using therapeutic apheresis
Home Institute: Beatson West of Scotland Cancer Centre Gartnavel General Hospital, Glasgow, United Kingdom
Host Institute: Institut de Cancérologie Gustave Roussy, Villejuif, France
Sponsor: Roche
Fellowship period: November 2014 – November 2016

Download the report

Amir Sonnenblick
Amir Sonnenblick

Project: Phsophorylated-STAT3 and trastuzumab resistance
Home Institute: The Hebrew University of Jerusalem- Hadassah Medical Center, Jerusalem, Israel
Host Institute: Institut Jules Bordet, Brussels, Belgium
Sponsor: Roche
Fellowship period: July 2014 – December 2015

Download the report

Michael Kolinsky
Michael Kolinsky

Project: Co-targeting of AKT and the Androgen Receptor for Advanced Prostate Cancer
Home Institute: University of Alberta Cross Cancer Institute, Edmonton, Alberta, Canada
Host Institute: The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK
Sponsor: Novartis
Fellowship period: October 2014 – December 2015



Antoine Hollebecque
Antoine Hollebecque

Project: Circulating Nucleic Acids as predictive biomarkers in Advanced Cancer Patients
Home Institute: Institut Gustave Roussy, Department of Medicine SITEP, Villejuif, France
Host Institute: Paterson Institute for Cancer Research, The University of Manchester, United Kingdom
Sponsor: Roche
Fellowship period: November 2013 – November 2014 

Noelia Tarazona Llavero
Noelia Tarazona

Project: FGFR2 in gastroesophageal cancer: prognosis, prediction and the effects of therapeutic intervention
Home Institute: Hospital Clinico Universitario de Valencia, Department Haematology and Medical Oncology, Valencia, Spain
Host Institute: The Royal Marsden NHS Foundation Trust, London, United Kingdom
Sponsor: Roche
Fellowship period: October 2013 - October 2015

Download the report

Daniela Morales-Espinosa
Daniela Morales Espinosa

Project: Characterization and potential clinical implications of the replication pathway in lung cancer
Home Institute: Instituto Nacional de Cancerología, Department: Clinical and Basic Research Sub-direction , Mexico City, Mexico
Host Institute: Catalan Institute of Oncology, Badalona, Barcelona, Spain
Sponsor: Roche
Fellowship period: August 2013 – August 2015

Aysegül Ilhan-Mutlu
Aysegul Ilhan-Mutlu

Project: Prevention of Brain Metastasis of Non-Squamous Non-Small Cell Lung Cancer By Antiangiogenic Therapy In Mice
Home Institute: Vienna General Hospital (AKH) - Medical University of Vienna, Department of Oncology, Vienna, Austria
Host Institute: University Clinic Heidelberg/Germany, German Cancer Research Centre, Heidelberg, Germany
Sponsor: Amgen
Fellowship period: October 2013 – September 2014 

Download the report

Tal Grenader
Tal Grenader

Project: Molecular resistance following personalised therapy in colorectal cancer (FOCUS-4 clinical fellow)
Home Institute: Shaare Zedek Medical Centre, Jerusalem, Israel
Host Institute: UCL, Cancer Institute, University College London, United Kingdom
Sponsor: Novartis
Fellowship period: November 2013 – November 2014

Guillermo Antonio De Velasco Oria
Guillermo Antonio De Velasco Oria

Project: Metabolomic study in renal cell carcinoma (RCC): patterns of relapsed and follow up
Home Institute: University Hospital 12 De Octubre, Medical Oncology, Madrid, Spain
Host Institute: Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Sponsor: Novartis
Fellowship period: September 2013 – August 2014  


Claudette Falato  
Claudette Falato

Project: Prognostic and predictive role of Ki67 determined on metastatic tissue of patients with advanced breast cancer
Home Institute: National Cancer Institute, Naples, Italy
Host institute: Karolinska University Hospital, Stockholm, Sweden
Sponsor: Roche
Fellowship period: April 2013 – March 2014

Jennifer Gibbons Marsico
Jennifer Gibbons Marsico

Project: Metabolomic and pharmacological patterns of resistance to the tyrosine kinase inhibitor sunitinib in patients with advanced renal-cell cancer
Home Institute: Instituto Nacional del Cancer (INCA), Montevideo, Uruguay
Host institute: Kantonsspital St Gallen, Switzerland
Sponsor: Roche
Fellowship period: January 2013 – Novemeber 2014

Angela Lamarca

Project: Feasibility evaluation of proliferation and nucleoside transport using FLT PET imaging in advanced pancreatic cancer patients
Home Institute: Hospital Universitario La Paz, Madrid, Spain
Host institute: The Christie NHS Foundation Trust, Manchester, UK
Sponsor: Amgen
Fellowship period: January 2013 – January 2015

Download the report

Elisabetta Pietri
Elisabetta Pietri

Project: Characterisation of individual foci of multicentric/multifocal breast cancer
Home institute: Istituto Tumori della Romagna I.R.S.T. , Meldola, Italy
Host institute: Institut Jules Bordet - Breast Cancer Translational Research Laboratory, Brussels, Belgium 
Sponsor: Amgen
Fellowship period: October 2012 – April 2014 

Loredana Vecchione
Loredana Vecchione

Project: Identification of multiple synthetic lethal interactions with the BRAF oncogene in colorectal cancer
Home institute: Katholieke Universities Leuven - Gasthuisberg University Hospital, Leuven, Belgium
Host institute: Department of Molecular Carcinogenesis B7 - NKI - Antoni van Leeuwenhoek Ziekenhuis - Prof Rene Bernards, Amsterdam, The Netherlands
Sponsor: Roche
Fellowship period: September 2013 – August 2014


Daniela Kolarevic
Daniela Kolarevic

Project: Identification and validation of targeted Therapeutics in triple negative breast cancer (Translational Research within Neobig programme)
Home institute: Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
Host institute: Breakthrough Breast Cancer Research Unit, Guy's and St. Thomas Hospital, London, UK
Sponsor: Roche
Fellowship period: 2011 (prolonged for a further year)

Sophie Postel-Vinay
Sophie Postel-Vinay

Project: Investigation of DNA repair deficiencies in Non Small Cell Lung Cancer and therapeutic applications using synthetic lethality
Home institute: Institut Gustave Roussy, Paris, France
Host institute: The Institute of Cancer Research, London, UK
Sponsor: Roche
Fellowship period: 2011 (prolonged for a further year)

Alejandra Armengol Alonso
 Alejandra Alonso

Project: Association between insulin resistance and pathologic response to neoadjuvant chemotherapy among women with operable hormone receptor negative breast cancer
Home Institute: Instituto Nacional De Ciencias Medicias y Nutricion, Mexico City, Mexico
Host Institute: Barcelona Hospital Universitari, Barcelona, Spain
Sponsor: Novartis
Fellowship period: March 2012 – February 2013

Download the report


Leticia De Mattos-Arruda
Leticia De Mattos Arruda

Project: Circulating tumour cells in metastatic breast cancer: it is time to detect and genotyping
Home institute: Santa Casa de Misericórdia de Belo Horizonte, Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brazil
Host institute: Vall d´Hebron University Hospital, Barcelona, Spain
Sponsor: Amgen
Fellowship period: August 2010 – August 2012 

Download the report

Hatem Azim
Hatem Azim

Project: Genomic Profiling of Breast Cancer diagnosed during pregnancy
Home institute: National Cancer Institute, Cairo Oncology Centre, Mohandeseen, Egypt
Host institute: Jules Bordet Institute, Brussels, Belgium 
Sponsor: Roche
Fellowship period: October 2010 – September 2012 

Download the report

Konstantinos-Vellios Kamposioras
Konstantinos Kamposioras

Project: Molecular characterisation of the stromal microenvironment in pancreatic adenocarcinoma and its role in tumour progression and prognosis
Home institute: University Hospital of Larissa, Greece
Host institute: St. James Institute of Oncology Level 4, Bexley Wing, St. James University Hospital, Leeds, UK
Sponsor: Roche
Fellowship period: 2011 – 2013 

Download the report

Michalis Karamouzis

Project: Molecular and genetic analysis of stromal fibroblasts in prostate cancer
Home institute: Medical School, University of Athens, Greece
Host institute: Department of Biological Chemistry, Medical School, University of Athens, Greece
Sponsor: Amgen
Fellowship period: 2010 – 2011  

Download the report

Giulia Pasello

Project: Identification of novel molecular targets and biological agents for the chemotherapy of malignant Pleural Mesothelioma
Home institute: Second Medical Oncology Unit, Instituto Oncologico Veneto, Padova Italy
Host institute: Department of Oncological and Surgical Sciences, Oncology Section, Istituto Oncologico Veneto, Padova, Italy
Sponsor: Roche
Fellowship period: July 2010 – July 2012

Download the report

Karin Tamas

Project: Exploring the tumour microenvironment with focus on Placental growth factor and colorectal cancer
Home institute: Szent Laszlo Teaching Hospital, Budapest, Hungary
Host institute: University Medical Center Groningen, The Netherlands
Sponsor: Roche
Fellowship period: September 2010 – September 2012 

Download the report

Teresa Troiani
Teresa Troiani

Project: Use of MEK inhibitors to overcome primary and acquired resistance to anti-EGFR therapies
Home institute: Oncologia Medica, Seconda Università Degli Studi di Napoli, Dipartimento di Internistica Clinica e Sperimentale "F. Magrassie E Lanzara", Naples, Italy
Host institute: Oncologia Medica, Seconda Università Degli Studi di Napoli, Dipartimento di Internistica Clinica e Sperimentale "F. Magrassie E Lanzara", Naples, Italy
Sponsor: Amgen
Fellowship period: August 2010 – August 2011

Michael Baumann

Project: Treatment of naïve and fludarabine-refractory CLL in the TCL-1 mouse model with IPI-926 and other hedgehog pathway inhibitors
Home Institute: Department of Medical Oncology, Kantonsspital, St. Gallen, Switzerland
Host Institute:Laboratory of Molecular Biology and Immunology CLL, Dept of Haematology and Oncology, University of Cologne, Germany
Sponsor: ESMO
Fellowship period: October 2010 – September 2011 

Download the report

Elena Castro Marcos

Project: Prostate Cancer Genetics and targeted screening
Home Institute: Centro de Investigacion del Cancer, Hospital Universitario de Salamanca, Spain
Host Institute: Royal Marsden Hospital NHS Trust, and The institute of Cancer Research, London, United Kingdom
Sponsor: Novartis
Fellowship period: October 2010 – September 2011 

Download the report

Last update: February 2022

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.